Proximal Humeral Comminuted Fractures in the Elderly - PERCELE Trial

Sponsor
University of Helsinki (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00999193
Collaborator
Helsinki University Central Hospital (Other), Finnish Institute for Health and Welfare (Other)
60
1
3
169
0.4

Study Details

Study Description

Brief Summary

Fractures of the proximal humerus are common in elderly patients. The optimal treatment of comminuted, displaced fractures is subject to controversy, and the results of operative treatment have not been shown to be superior to conservative treatment. The aim of the study is to compare locking plate osteosynthesis versus treatment with fracture hemiarthroplasty versus conservative treatment in a randomised, controlled protocol. The results of treatment are measured at 6 weeks, 3 months, 6 months, 12 months and 24 months. Main outcome measures are Pain at rest and activity (NRSs) and functional assessment of the shoulder with Constant Score. Secondary outcome measures are Simple Shoulder test (SST), Disabilities of the Arm, Shoulder and Hand (DASH), quality of life assessment (15D), subjective patient satisfaction and costs. The study also has a cohort follow-up of the patiens who decline randomisation.

The recruitment target was 90 patients, but the study recruitment was stopped due to slow recruitment (too few patients presenting with eligibile injury to the hospital) at 60 patients in November 2019.

Condition or Disease Intervention/Treatment Phase
  • Procedure: locking plate, ORIF
  • Procedure: Hemiarthroplasty
  • Other: Conservative treatment
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effectiveness and Cost-effectiveness of Conservative and Operative Treatment of Three- and Four-part Fractures of the Proximal Humerus. A Nested Randomised Controlled Trial and Cohort Study
Study Start Date :
Nov 1, 2010
Anticipated Primary Completion Date :
Oct 1, 2021
Anticipated Study Completion Date :
Dec 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Conservative Treatment

Other: Conservative treatment
Immobilisation in a supporting brace for 3 weeks, then increasingly active rehabilitation program supported by a physiotherapist until 12 weeks of the injury.

Experimental: ORIF w. locking plate, no luxation

Procedure: locking plate, ORIF
Open reduction of the fracture (and GH joint), internal fixation with a locking plate. Tuberculum fragments are sutured to the plate with thick non-absorbable suture.

Experimental: Hemiarthroplasty, no luxation

Procedure: Hemiarthroplasty
Replacement of the humeral articular head with hemiprosthesis. Tubercles are sutured to the prosthesis with thick nonabsorbable sutures.

Outcome Measures

Primary Outcome Measures

  1. Pain at rest Numeric Rating Scale 0-10 (NRS) [6 weeks, 3 mo, 6 mo, 1 year, 2 years]

  2. Pain in active motion NRS [6 weeks, 3 mo, 6 mo, 1 year, 2 years]

  3. Constant Score [3 mo, 6 mo, 1 year, 2 years]

Secondary Outcome Measures

  1. Simple Shoulder Test (SST) [3 mo, 6 mo, 1 year, 2 years]

  2. Disabilities of the Arm, Shoulder and Hand (DASH) [3 mo, 6 mo, 1 year, 2 years]

  3. Quality of life assessed with 15D [6 weeks, 3 mo, 6 mo, 1 year, 2 years]

  4. Subjective satisfaction [6 weeks, 3 mo, 6 mo, 1 year, 2 years]

  5. Complications [6 weeks, 3 mo, 6 mo, 1 year, 2 years]

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 65 years and older

  • Acute trauma: 1. randomisation (op vs cons) within 7 days of injury.

  • 3- or 4-part fracture with >5mm dislocation of the anatomic neck.

  • AO classification C1-2 for non-luxation fractures

  • AO classification C3 for luxation fractures

Exclusion Criteria:
  • Head Splitting fracture

  • Open fracture

  • Additional fractures in the shoulder region

  • Other injuries requiring surgical treatment

  • Clinically significant injury of the brachial plexus or vasculature

  • Pathological fracture associated with cancer

  • History of a fracture of the clavicle, scapula or humerus, or history of a very significant disease or trauma of the shoulder region (hemiparesis, tumour, osteomyelitis, grave arthrosis etc)

  • Rheumatoid Arthritis in the shoulder requiring active treatment

  • Reduced co-operation or incapability for independent living (dementia, mental illness, drug- or alcohol abuse etc)

  • unwillingness to accept some of the treatment options.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Töölö Hospital Trauma Center, Helsinki University Central Hospital, Helsinki Finland

Sponsors and Collaborators

  • University of Helsinki
  • Helsinki University Central Hospital
  • Finnish Institute for Health and Welfare

Investigators

  • Principal Investigator: Tuomas Lähdeoja, MD, University of Helsinki
  • Study Director: Mika Paavola, MD, PhD, University of Helsinki
  • Study Director: Jarkko Pajarinen, MD, PhD, University of Helsinki
  • Study Chair: Seppo Koskinen, MD, PhD, University of Helsinki

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Tuomas Lahdeoja, MD, University of Helsinki
ClinicalTrials.gov Identifier:
NCT00999193
Other Study ID Numbers:
  • HUS-428/13/03/02/08
First Posted:
Oct 21, 2009
Last Update Posted:
May 6, 2020
Last Verified:
May 1, 2020
Keywords provided by Tuomas Lahdeoja, MD, University of Helsinki
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2020